A detailed history of Royal Fund Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Royal Fund Management, LLC holds 15,800 shares of NTRA stock, worth $2.66 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
15,800
Previous 8,500 85.88%
Holding current value
$2.66 Million
Previous $920,000 118.26%
% of portfolio
0.12%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$97.75 - $129.67 $713,575 - $946,590
7,300 Added 85.88%
15,800 $2.01 Million
Q2 2024

Jul 18, 2024

BUY
$85.28 - $112.6 $724,880 - $957,100
8,500 New
8,500 $920,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Royal Fund Management, LLC Portfolio

Follow Royal Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.